161 related articles for article (PubMed ID: 36802486)
1. Reduction of Reactive Oxygen Species Accumulation Using Gadolinium-Doped Ceria for the Alleviation of Atherosclerosis.
Gao Y; Liu S; Zeng X; Guo Z; Chen D; Li S; Tian Z; Qu Y
ACS Appl Mater Interfaces; 2023 Mar; 15(8):10414-10425. PubMed ID: 36802486
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-guided assembly of ceria nanozymes as plaque-targeting ROS scavengers for anti-atherosclerotic therapy.
Wang S; Zhang J; Li W; Chen D; Tu J; Sun C; Du Y
Carbohydr Polym; 2022 Nov; 296():119940. PubMed ID: 36087989
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin-Modified CeO
Wu L; Liu G; Wang W; Liu R; Liao L; Cheng N; Li W; Zhang W; Ding D
Int J Nanomedicine; 2020; 15():2515-2527. PubMed ID: 32368038
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium Doping Modulates the Enzyme-like Activity and Radical-Scavenging Properties of CeO
Sozarukova MM; Kozlova TO; Beshkareva TS; Popov AL; Kolmanovich DD; Vinnik DA; Ivanova OS; Lukashin AV; Baranchikov AE; Ivanov VK
Nanomaterials (Basel); 2024 Apr; 14(9):. PubMed ID: 38727363
[TBL] [Abstract][Full Text] [Related]
5. Catalytic Tunable Black Phosphorus/Ceria Nanozyme: A Versatile Oxidation Cycle Accelerator for Alleviating Cisplatin-Induced Acute Kidney Injury.
Gao X; Wang B; Li J; Niu B; Cao L; Liang XJ; Zhang J; Jin Y; Yang X
Adv Healthc Mater; 2023 Dec; 12(30):e2301691. PubMed ID: 37677811
[TBL] [Abstract][Full Text] [Related]
6. ROS scavenging Mn
Yao J; Cheng Y; Zhou M; Zhao S; Lin S; Wang X; Wu J; Li S; Wei H
Chem Sci; 2018 Mar; 9(11):2927-2933. PubMed ID: 29732076
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.
Yin JJ; Lao F; Meng J; Fu PP; Zhao Y; Xing G; Gao X; Sun B; Wang PC; Chen C; Liang XJ
Mol Pharmacol; 2008 Oct; 74(4):1132-40. PubMed ID: 18635669
[TBL] [Abstract][Full Text] [Related]
8. Cerium oxide nanozyme attenuates periodontal bone destruction by inhibiting the ROS-NFκB pathway.
Yu Y; Zhao S; Gu D; Zhu B; Liu H; Wu W; Wu J; Wei H; Miao L
Nanoscale; 2022 Feb; 14(7):2628-2637. PubMed ID: 35088792
[TBL] [Abstract][Full Text] [Related]
9. Oxygen Vacancies Enhanced CeO
Shao C; Shen A; Zhang M; Meng X; Song C; Liu Y; Gao X; Wang P; Bu W
ACS Nano; 2018 Dec; 12(12):12629-12637. PubMed ID: 30495921
[TBL] [Abstract][Full Text] [Related]
10. Engineering the defect state and reducibility of ceria based nanoparticles for improved anti-oxidation performance.
Wang YJ; Dong H; Lyu GM; Zhang HY; Ke J; Kang LQ; Teng JL; Sun LD; Si R; Zhang J; Liu YJ; Zhang YW; Huang YH; Yan CH
Nanoscale; 2015 Sep; 7(33):13981-90. PubMed ID: 26228305
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory and antioxidant effect of cerium dioxide nanoparticles immobilized on the surface of silica nanoparticles in rat experimental pneumonia.
Serebrovska Z; Swanson RJ; Portnichenko V; Shysh A; Pavlovich S; Tumanovska L; Dorovskych A; Lysenko V; Tertykh V; Bolbukh Y; Dosenko V
Biomed Pharmacother; 2017 Aug; 92():69-77. PubMed ID: 28531802
[TBL] [Abstract][Full Text] [Related]
12. Engineering ROS-scavenging Prussian blue nanozymes for efficient atherosclerosis nanotherapy.
Chen X; Dai C; Hu R; Yu L; Chen Y; Zhang B
J Mater Chem B; 2023 Mar; 11(9):1881-1890. PubMed ID: 36723250
[TBL] [Abstract][Full Text] [Related]
13. Ceria Nanozymes with Preferential Renal Uptake for Acute Kidney Injury Alleviation.
Zhang DY; Liu H; Li C; Younis MR; Lei S; Yang C; Lin J; Li Z; Huang P
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56830-56838. PubMed ID: 33319561
[TBL] [Abstract][Full Text] [Related]
14. Catalytically proficient ceria nanodots supported on redox-active mesoporous hosts for treatment of inflammatory bowel disease
Wang H; Wang L; Chen Y; Huang J; Xing Y; Wang L; Zhang J; Yang H
J Mater Chem B; 2023 Nov; 11(43):10369-10382. PubMed ID: 37873599
[TBL] [Abstract][Full Text] [Related]
15. CeO
Zhong H; Jiang C; Zou J; Zhu G; Huang Y
Inorg Chem; 2023 Aug; 62(33):13168-13172. PubMed ID: 37555763
[TBL] [Abstract][Full Text] [Related]
16. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
[TBL] [Abstract][Full Text] [Related]
17. Gold nanoparticles-embedded ceria with enhanced antioxidant activities for treating inflammatory bowel disease.
Li M; Liu J; Shi L; Zhou C; Zou M; Fu D; Yuan Y; Yao C; Zhang L; Qin S; Liu M; Cheng Q; Wang Z; Wang L
Bioact Mater; 2023 Jul; 25():95-106. PubMed ID: 36789001
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Cerium Oxide Nanoparticle Valence State on Reactive Oxygen Species and Toxicity.
Dunnick KM; Pillai R; Pisane KL; Stefaniak AB; Sabolsky EM; Leonard SS
Biol Trace Elem Res; 2015 Jul; 166(1):96-107. PubMed ID: 25778836
[TBL] [Abstract][Full Text] [Related]
19. Enhanced production of reactive oxygen species by gadolinium oxide nanoparticles under core-inner-shell excitation by proton or monochromatic X-ray irradiation: implication of the contribution from the interatomic de-excitation-mediated nanoradiator effect to dose enhancement.
Seo SJ; Han SM; Cho JH; Hyodo K; Zaboronok A; You H; Peach K; Hill MA; Kim JK
Radiat Environ Biophys; 2015 Nov; 54(4):423-31. PubMed ID: 26242374
[TBL] [Abstract][Full Text] [Related]
20. Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease.
Cao Y; Cheng K; Yang M; Deng Z; Ma Y; Yan X; Zhang Y; Jia Z; Wang J; Tu K; Liang J; Zhang M
J Nanobiotechnology; 2023 Jan; 21(1):21. PubMed ID: 36658555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
